Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. L-citrulline Dl-malate (1:1)
2. 54940-97-5
3. 70796-17-7
4. L-citrulline Dl-malate
5. Stimol
6. L-citrulline Malate
7. Citrulline Malate [who-dd]
8. L-citrulline,dl-malate
9. Pab4036kho
10. L-citrulline Dl-malate(1:1)
11. L-ornithine, N5-(aminocarbonyl)-, 2-hydroxybutanedioate (1:1)
12. L-ornithine, N5-(aminocarbonyl)-, Hydroxybutanedioate (1:1)
13. (2s)-2-amino-5-(carbamoylamino)pentanoic Acid;2-hydroxybutanedioic Acid
14. (s)-2-amino-5-ureidopentanoic Acid Compound With 2-hydroxysuccinic Acid (1:1)
15. L-citrulline-dl-malate
16. Unii-pab4036kho
17. (s)-2-amino-5-ureidopentanoic Acid 2-hydroxysuccinic Acid Salt
18. Stimol (tn)
19. Citrulline Malate (salt)
20. (2s)-2-amino-5-(carbamoylamino)pentanoic Acid; 2-hydroxybutanedioic Acid
21. Schembl319676
22. L-citrulline Dl-malate 2:1
23. Chembl4297667
24. Dtxsid60970275
25. Bcp11994
26. Mfcd09839004
27. Akos015919504
28. Citrulline Malate (salt) [mi]
29. Gs-3899
30. Cs-0083737
31. D07707
32. A830416
33. A914153
34. Q27286437
35. (2s)-2-amino-5-ureido-pentanoic Acid; 2-hydroxybutanedioic Acid
36. Di-tert-butyl1-(tert-butylthio)-1,2-hydrazinedicarboxylate
37. 2-hydroxybutanedioic Acid--n~5~-[hydroxy(imino)methyl]ornithine (1/1)
| Molecular Weight | 309.27 g/mol |
|---|---|
| Molecular Formula | C10H19N3O8 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 8 |
| Exact Mass | 309.11721457 g/mol |
| Monoisotopic Mass | 309.11721457 g/mol |
| Topological Polar Surface Area | 213 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
FDF Dossiers
Regulatory Info :
Registration Country : South Korea
Brand Name : Citmol Solution
Dosage Form : Solution
Dosage Strength : 100MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info :
Registration Country : South Korea
Brand Name : Citmol Solution
Dosage Form : Solution
Dosage Strength : 100MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging :
Regulatory Info :
Dosage : Solution
Dosage Strength : 100MG/ML
Brand Name : Citmol Solution
Approval Date :
Application Number :
Registration Country : South Korea
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
09 Aug 2023
Reply
28 Nov 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Citrulline Malate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Citrulline Malate, including repackagers and relabelers. The FDA regulates Citrulline Malate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Citrulline Malate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Citrulline Malate supplier is an individual or a company that provides Citrulline Malate active pharmaceutical ingredient (API) or Citrulline Malate finished formulations upon request. The Citrulline Malate suppliers may include Citrulline Malate API manufacturers, exporters, distributors and traders.
Citrulline Malate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Citrulline Malate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Citrulline Malate GMP manufacturer or Citrulline Malate GMP API supplier for your needs.
A Citrulline Malate CoA (Certificate of Analysis) is a formal document that attests to Citrulline Malate's compliance with Citrulline Malate specifications and serves as a tool for batch-level quality control.
Citrulline Malate CoA mostly includes findings from lab analyses of a specific batch. For each Citrulline Malate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Citrulline Malate may be tested according to a variety of international standards, such as European Pharmacopoeia (Citrulline Malate EP), Citrulline Malate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Citrulline Malate USP).
LOOKING FOR A SUPPLIER?
Comment (4)
